NEW YORK (
) -- Better-than-expected results from drug major
(PFE - Get Report)
spurred buying in pharmaceutical and healthcare ETFs. Pfizer blew past estimates, helped by the acquisition of
and higher sales. The stock is up nearly 5% at $16.25.
, which counts
Johnson & Johnson
(JNJ - Get Report)
, Pfizer and
(MRK - Get Report)
among its top holdings is rising 1.4% on Tuesday early trading. The
iShares Dow Jones US Healthcare
SPDR Health Care Sector
are also heading higher.
Weak economic data appears to be driving buyers to safe havens like gold. The
SPDR Gold ETF
is up 0.6% to $116.30. Gold mining companies, a riskier way to invest in gold, is also seeing buying interest. The
Market Vectors Junior Gold Miners ETF
is gaining 2.3%.
A blowout quarter from
and reports that a South Korean company is going to acquire a 49.9% stake in the Chinese solar module maker, is boosting buying in solar ETFs. The
Market Vectors Solar ETF
is up 1.6% in Tuesday early trading, while
Claymore/MAC Solar Energy ETF
is up 1.1%.
-- Reported by Shanthi Venkataraman in New York.
Follow TheStreet.com on
and become a fan on